Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines
Obesity is a chronic disease, whose incidence is alarmingly growing. It is associated with metabolic abnormalities and cardiovascular complications. These complications are clustered in the metabolic syndrome (MetS) leading to high cardiovascular morbidity and mortality. Obesity predisposes to diab...
Saved in:
Main Authors: | Manfredi Tesauro, Maria Paola Canale, Giuseppe Rodia, Nicola Di Daniele, Davide Lauro, Angelo Scuteri, Carmine Cardillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.4061/2011/653182 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin
by: M. Tesauro, et al.
Published: (2012-01-01) -
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Tania Romacho, et al.
Published: (2013-01-01) -
Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis
by: Zhang Q, et al.
Published: (2025-01-01) -
Exercise Induced Adipokine Changes and the Metabolic Syndrome
by: Saeid Golbidi, et al.
Published: (2014-01-01) -
Obesity-Related Metabolic Syndrome and Vascular Complications
by: Manfredi Tesauro, et al.
Published: (2013-01-01)